← Back
$MPLT All transactions

MapLight Therapeutics, Inc.

A

$ Value

$0

Shares

6,020

Price

$0

Filed

Feb 9

Insider

Name

Kreitzer Anatol

Title

Chief Discovery Officer

CIK

0002021238

Roles

Officer

Transaction Details

Transaction Date

2026-02-05

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

259,928

Footnotes

Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on January 1, 2027, and 1/16th of the RSUs shall vest on each subsequent April 1, July 1, October 1 and January 1 thereafter, subject to the Reporting Person's continued service through each vesting date. | Each RSU represents a contingent right to receive one share of voting common stock of the Issuer. | 1/4th of the total shares underlying the option shall vest on February 5, 2027, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.

Filing Info

Accession No.

0002021238-26-000004

Form Type

4

Issuer CIK

0001770069

Kreitzer Anatol's History

Date Ticker Type Value
2026-04-15 MPLT $88K
2026-02-05 MPLT A $0
2026-02-05 MPLT A $0
2026-01-27 MPLT F $757K
2025-10-27 MPLT A $0
2025-10-27 MPLT A $0

Other Insiders at MPLT (90d)

Insider Bought Sold Last
Pavlov George $441K 2026-02-20
Garnett Timothy John $253K 2026-02-10
Kroeger Christopher A.
Chief Executive Officer
$521K 2026-04-16
GILLIS JONATHAN
CAAO and PAO
$96K 2026-04-15
Lillie James Woodruff
Chief Scientific Officer
$123K 2026-04-16
Hanson Kristopher
General Counsel
$49K 2026-04-16
Malenka Robert C. $1.6M 2026-04-15
Foff Erin Pennock
Chief Medical Officer
$87K 2026-04-16
Kreitzer Anatol
Chief Discovery Officer
$88K 2026-04-15
Setia Vishwas
Chief Financial Officer
$79K 2026-04-16